- 10x Genomics announced multi-project research collaboration with Fred Hutch Cancer Center.
- First project: bladder cancer - use Flex Apex and Xenium platforms to correlate drug target expression and tumor microenvironment with treatment response.
- Second project: AML - use Flex Apex for residual disease detection.
- This is 10x's first clinical research initiative into blood cancers.
- Collaboration builds on prior partnerships and 10x's planned CLIA-certified laboratory.
- 10x and Fred Hutch plan to build a framework for future clinical reporting.
The headline and the read are open. The reasons are one free account away, on every story.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
BORSAPLUSWhy it matters · Bull and bear case · Reaction against SPY and the sector · What to watch
Create a free account · no card